HCW Biologics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $51.2M | $11.7M |
| FY2022 | $6.4M | $37.4M | $22.3M |
| FY2023 | $6.3M | $13.5M | $3.6M |
| FY2024 | $7.4M | $-6.8M | $4.7M |
| FY2025 | $0 | $2.8M | $2.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $51.2M | $11.7M |
| FY2022 | $6.4M | $37.4M | $22.3M |
| FY2023 | $6.3M | $13.5M | $3.6M |
| FY2024 | $7.4M | $-6.8M | $4.7M |
| FY2025 | $0 | $2.8M | $2.0M |